Health Economics and Genomics: What do we know and what remains to be done?
Unravelling the human genome is one of the most remarkable achievements of our generation. This seminar will answer questions about the scope of the impact of genomic medicine and how it fits with our economic and the policy environment. It will report on our findings of cost effectiveness of the use of genomic testing and the scale of the impacts of genetic conditions on the social and economic prospects of families. It will also address questions such as: * Where will the health benefits first come from? * Is our policy environment ready for genomics? * What type of costs and savings can we anticipate in the future? * Which government portfolios will be most impacted? * Measuring the costs and benefits